Globus Medical (GMED) Tops Q3 EPS by 5c

Globus Medical (NYSE: GMED) reported Q3 EPS of $0.50, $0.05 better than the analyst estimate of $0.45. Revenue for the quarter came in at $229.7 million versus the consensus estimate of $228.31 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Cintas beats estimates but stock edges lower